Rapamycin lotion reduces facial tumors caused by tuberous sclerosis, team reports

Working on a promising treatment for facial tumors tied to tuberous sclerosis complex, from the left, are Adelaide Hebert, M.D.; John Slopis, M.D.; Mary Kay Koenig, M.D.; Joshua Samuels, M.D., M.P.H.; and Hope Northrup, M.D. All are from McGovern Medical School at UTHealth in Houston with the exception of Slopis, who is with The University of Texas MD Anderson Cancer Center.